Privi Speciality Chemicals
Market cap ₹13,431 Cr
- P/E
- 36.01
- Day range
- ₹3,384.10 – ₹3,459.20
- 52-week range
- ₹2,570.80 – ₹3,785.30
- Volume
- 49,342
- Open
- ₹3,420.00
- Prev close
- ₹3,430.70
Latest results · Q2 FY27(consolidated)Revenue ₹760 Cr+12.0%Profit ₹118 Cr+30.3%Margin 15.5%YoY vs the same quarter last year
1 red flag to read up on
- medium
Promoter holding falling
60.60%, down 9.29 pts since 2025-09-30 · 30 Sept 2026
From NSE and BSE filings. A flag is a reason to read the filing, not a rating.
PRIVISCL in NSE indices and F&O
Research profile
Composite 63 / 100Factor percentiles
Derived metrics
- Earn. yield
- 2.8%
- Graham no.
- ₹941.12
- vs Graham
- -72.6%
- ROE ÷ P/B
- 3.0%
- 12-1 mom.
- -1.1%
- Return / vol
- 0.04
- Magic Formula
- #243
- Piotroski
- 6/6
- FCF yield
- 1.7%
Appears in 9 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 44 in Chemicals| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Solar IndustriesSOLARINDS | ₹1.68 L Cr | 74.04 | 22.19 | 32.5% | 38.0% | 29.0% | 0.23 | +69.0% |
| Pidilite IndustriesPIDILITIND | ₹1.56 L Cr | 58.12 | 14.05 | 24.0% | 31.0% | 20.0% | 0.03 | +20.9% |
| SRF LtdSRF | ₹72,471 Cr | 31.75 | 4.80 | 13.8% | 15.0% | 19.0% | 0.35 | +34.7% |
| Linde IndiaLINDEINDIA | ₹58,548 Cr | 118.46 | 13.42 | 13.6% | 18.0% | 32.0% | 0.23 | +12.3% |
| Coromandel InternationalCOROMANDEL | ₹57,701 Cr | 37.01 | 4.30 | 16.1% | 22.0% | 9.0% | 0.12 | +6.6% |
| Gujarat FluorochemicalsFLUOROCHEM | ₹52,952 Cr | 78.39 | 6.17 | 7.6% | 10.0% | 27.0% | 0.28 | +45.5% |
| Navin Fluorine InternationalNAVINFLUOR | ₹52,759 Cr | 57.95 | 11.37 | 20.1% | 21.0% | 34.0% | 0.28 | +57.1% |
| Privi Speciality ChemicalsPRIVISCL | ₹13,431 Cr | 36.01 | 8.35 | 25.2% | 22.0% | 26.0% | 0.63 | +11.9% |
| Sector median | ₹13,505 Cr | 31.75 | 2.86 | 9.9% | 12.0% | 15.7% | 0.27 | +21.5% |
Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 9h agoHeadlines about Privi Speciality Chemicals from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 35.2
- Price / Book
- 8.53
- ROE (FY26)
- 25.2%
- ROCE (latest year)
- 22%
- Dividend yield
- 0.30%
Moving averages (NSE)
- 20-day
- ₹3,356.62
- Price above
- 50-day
- ₹3,426.47
- Price above
- 200-day
- ₹3,292.65
- Price above
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- Public
- DII
- FII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 404 | 484 | 464 | 533 | 491 | 614 | 559 | 679 | 605 | 722 | 666 | 760 |
| YoY Sales growth | -4 | — | — | — | — | — | — | — | — | — | — | — |
| Expenses | 314 | 393 | 370 | 423 | 378 | 481 | 427 | 497 | 453 | 541 | 514 | 561 |
| Operating Profit | 90 | 91 | 94 | 110 | 113 | 133 | 132 | 182 | 151 | 180 | 152 | 200 |
| OPM % | 22% | 19% | 20% | 21% | 23% | 22% | 24% | 27% | 25% | 25% | 23% | 26% |
| Other Income | 6 | 8 | 3 | 4 | 2 | 15 | 9 | 0 | 7 | 4 | 15 | 13 |
| Interest | 24 | 25 | 22 | 22 | 22 | 23 | 24 | 21 | 19 | 18 | 17 | 17 |
| Depreciation | 32 | 30 | 32 | 32 | 32 | 35 | 36 | 36 | 36 | 36 | 37 | 37 |
| Profit before tax | 39 | 44 | 43 | 61 | 61 | 90 | 81 | 125 | 104 | 130 | 113 | 159 |
| Tax % | 26% | 28% | 27% | 26% | 27% | 29% | 29% | 28% | 28% | 27% | 27% | 26% |
| Net Profit | 29 | 32 | 31 | 45 | 44 | 64 | 58 | 90 | 75 | 94 | 83 | 118 |
| EPS in Rs | ₹7.36 | ₹7.93 | ₹8.02 | ₹11.42 | ₹11.37 | ₹17.01 | ₹15.84 | ₹24.02 | ₹19.95 | ₹23.96 | ₹21.54 | ₹29.93 |
From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
+7 days since Mar 2021
+65 days since Mar 2021
+67 days since Mar 2021
+5 days since Mar 2021
-11 days since Mar 2021
Strengths, risks & growth
Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances. [1]
Strengths
- Company has delivered good profit growth of 26.8% CAGR over last 5 years
Risks
- Stock is trading at 8.35 times its book value
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -13.4%
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- +15%
- 3 Years
- +17%
- TTM
- +18%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- +27%
- 3 Years
- +144%
- TTM
- +40%
Stock Price CAGR
- 10 Years
- +25%
- 5 Years
- +16%
- 3 Years
- +38%
- 1 Year
- +1%
Return on Equity
- 10 Years
- +15%
- 5 Years
- +15%
- 3 Years
- +19%
- Last Year
- +26%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 60.60% | 60.60% | 60.60% | 60.60% | 0.00 pp |
| FII | 1.64% | 1.37% | 1.94% | 2.78% | +0.84 pp |
| DII | 10.25% | 10.67% | 10.07% | 8.96% | -1.11 pp |
| Public | 27.51% | 27.36% | 27.39% | 27.64% | +0.25 pp |
Filed with NSE for Sept 2026: promoters 60.60%, public 39.40%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 7.46% (-1.09 pp)- Promoters60.6%
- Foreign institutions2.8%
- Mutual funds7.5%
- Insurance0.0%
- Other domestic institutions1.5%
- Retail10.1%
- Others17.6%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| SBI Small Cap Fund | 4.56% | 1.56% | -0.16 pp |
| Bank of India Small Cap Fund | 0.24% | 0.87% | +0.87 pp |
| SBI MNC Fund | 0.21% | 0.46% | -0.61 pp |
| TRUSTMF Small Cap Fund | 0.18% | 0.59% | -0.64 pp |
| SBI Children's Fund-Investment Plan | 0.12% | 0.21% | -2.82 pp |
Scorecard
- Performance
- Avg
- Valuation
- High
- Growth
- High
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 34.3%
- Downside volatility
- 33.8%
- Worst 5% of days
- 3.0%
- Average of that tail
- 4.8%
- Max drawdown (1Y)
- 22.8%
- Below its peak
- 8.3%
Against the market
- Beta vs Nifty 50
- 0.53
- Correlation
- 0.21
- Relative strength (3M)
- -4.2%
- ATR (14)
- 3.6%
Return
- Return 1M
- +2.7%
- Return 3M
- -0.3%
- Return 6M
- +11.1%
- Return 1Y
- +1.5%
- vs 200-day average
- +4.4%
Momentum
- RSI (14)
- 53.4
- MACD histogram
- 16.27
- Stochastic %K
- 67.4
- ADX (14)
- 15.2
- +DI / −DI
- 19.0 / 19.3
- Money flow index
- 41.0
Participation
- Delivery (20d avg)
- 56.5%
- vs its 60-day baseline
- -1.8 pts
- Volume vs 20-day
- -0.8σ
- Close vs day's VWAP
- +0.3%
- 52-week position
- 78 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
Piotroski F-Score
6 of 6 tested
- Return on assets positive — passed
- Operating cash flow positive — not testableno cash flow statement for this period
- Return on assets improving — passed
- Cash flow exceeds profit — not testableneeds cash flow and profit against assets
- Debt to assets falling — passed
- Current ratio improving — passed
- No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
- Operating margin improving — passed
- Asset turnover improving — passed
- Free cash flow
- ₹230 Cr
- FCF yield
- 1.7%
- Cash conversion
- 1.74
- Accruals ratio
- -0.074
- Net debt
- ₹918 Cr
- Net debt / equity
- 0.58
- EV / sales
- 5.21
- Capex intensity
- 12.5%
- Revenue CAGR
- 15.4%
- Profit CAGR
- 49.9%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Insider trades
| Person | Type | Shares | Value | Disclosed |
|---|---|---|---|---|
Vivira Investment & Trading Private Limited Promoters · Market Sale | Sell | 36,28,627 | ₹1030 Cr | 31 Dec 2025 |
Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.
Corporate actions
- dividend₹5.00
Interim Dividend - Rs 5 Per Share
4 Nov 2026ex-date - dividend₹10.00
Dividend - Rs 10 Per Share
31 Jul 2026ex-date - dividend₹5.00
Dividend - Rs 5 Per Share
24 Jul 2025ex-date - otherNot available — not reported in this filing
Annual General Meeting
24 Jul 2024ex-date - dividend₹2.00
Dividend - Rs 2 Per Share
24 Jul 2024ex-date - otherNot available — not reported in this filing
Annual General Meeting
3 Aug 2023ex-date - dividend₹2.00
Dividend - Rs 2 Per Share
20 Sept 2022ex-date - otherNot available — not reported in this filing
Annual General Meeting
20 Sept 2022ex-date - dividend₹2.00
Dividend - Rs 2 Per Share
17 Aug 2021ex-date - otherNot available — not reported in this filing
Annual General Meeting
17 Aug 2021ex-date - dividend₹1.50
Annual General Meeting/Dividend - Rs 1.50 Per Share
26 Oct 2020ex-date - otherNot available — not reported in this filing
Demerger
21 Aug 2020ex-date - dividend₹2.50
Annual General Meeting/Dividend - Rs 2.50 Per Share
1 Aug 2019ex-date - dividend₹1.50
Annual General Meeting/ Dividend- Rs 1.50 Per Share
2 Aug 2018ex-date - dividendNot available — not reported in this filing
Annual General Meeting/Dividend - Re 1/- Per Share
3 Aug 2017ex-date - dividend₹2.50
Annual General Meeting/Dividend - Rs 2.50 Per Share
1 Sept 2016ex-date - dividend₹2.50
Annual General Meeting/Dividend - Rs 2.50/- Per Share
19 Jun 2015ex-date
Company announcements
Announcement under Reg 30 - Transcript of Q2 Earnings Call held on October 30, 2026.
Outcome of Earnings Call held on 30.10.2026 @ 04:00 pm - Audio Link
Investor Presentation - Financial & Operational Review for Quarter and half year ended September 30,2026.
Outcome of Board Meeting held on October 29.10.2026 to consider and approve Financial Results of Q2 FY27, declaration of Interim Dividned and Proposed investment in Solar Power Project.
Outcome of Board Meeti ng - Approving Record Date for the purpose of Interim Dividend
Outcome of Board Meeting - Approval of 1st Interim Dividned FY 2026-27
Outcome of Board Meeting - Financial Results for quarter and half year ended September 30, 2026
Outcome of the Board Meeting held on October 29, 2026 inter alia to consider & approve Financial Results for quarter and half year ended September 30, 2026 & declaration of first Interim ....
Scrutinizer's Report on the voting results of the business transacted at the Shareholders Meeting convened pursuant to the order dated September 07,2026 of the Honble National Company ....
Summary of the proceedings of the NCLT Convened Meeting of the Equity Shareholders of the Company held on Tuesday, Octobers 27,2026.
Analyst/ Invetors Meet - Intimation to be held on Friday, October 30,2026.
Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Intimation of Board ....
Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026.
Notice of Hon'ble NCLT Convened Shareholders Meeting in the matter of Scheme of Amalgamation, Scheduled to be held on Tuesday, October 27, 2026 At 12:30 p.m.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Funds
Filed with BSE (scrip 530117); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Aug 2026TranscriptSlidesRecording
- May 2026TranscriptSlidesRecording
- Feb 2026TranscriptSlidesRecording
- Nov 2025TranscriptSlidesRecording
- Aug 2025TranscriptSlidesRecording
Credit ratings
- Rating update · 30 Jun from icra
- Rating update · 20 Apr from crisil
- Rating update · 10 Mar 2025 from crisil
- Rating update · 21 May 2024 from crisil
- Rating update · 20 Sep 2023 from crisil
- Rating update · 30 Sep 2022 from crisil
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 29 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Privi Speciality Chemicals: common questions
Answered from the figures on this page.